Literature DB >> 3169056

Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy.

G M Sundkvist1, L Ahlgren, B Lilja, S Mattsson, P A Abrahamsson, L B Wadström.   

Abstract

Bone scintigraphy was performed in 16 men with newly diagnosed prostatic carcinoma before orchiectomy as well as 2 weeks and 2 months after operation. The uptake in the lower thoracic and lumbar vertebrae was registered up to 240 min after injection of 99mTc-MDP and was then calculated for each patient and vertebra. The relative standard deviation in measured uptake due to measuring technique was estimated to be +/- 7%. In eight patients, who had normal bone scintigraphies before orchiectomy, there were no changes in the uptake values after operation. The remaining eight patients had widespread metastatic involvement prior to treatment. Six of these patients showed a so called "flare phenomenon" in the abnormal vertebrae which means an initial increase in uptake after operation followed by a decreased uptake in response to therapy. One patient had a continuously increased uptake in all the abnormal vertebrae which correlated well with the clinical progression of the disease, while in another patient both reactions were seen. Thus, repeated quantitative bone scintigraphies using 99mTc-MDP can be made in a reproducible way and can be a useful tool to follow a patient's response to treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169056     DOI: 10.1007/bf00257328

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  17 in total

1.  Strontium-87m and the gamma camera in the study of bone metastases from carcinoma of the prostate.

Authors:  M R Robinson; A R Constable
Journal:  Br J Urol       Date:  1973-04

2.  Nuclear bone imaging in metastatic cancer of the prostate.

Authors:  J J Pollen; K Gerber; W L Ashburn; J D Schmidt
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

3.  Accuracy of 99mTC-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases.

Authors:  J D Osmond; H P Pendergrass; M S Potsaid
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-12

4.  Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.

Authors:  P J Gillespie; J L Alexander; G A Edelstyn
Journal:  J Nucl Med       Date:  1975-03       Impact factor: 10.057

5.  Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.

Authors:  R M Levenson; B J Sauerbrunn; H R Bates; R D Newman; J L Eddy; D C Ihde
Journal:  Radiology       Date:  1983-02       Impact factor: 11.105

6.  The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

Authors:  J J Pollen; K F Witztum; W L Ashburn
Journal:  AJR Am J Roentgenol       Date:  1984-04       Impact factor: 3.959

7.  Serial bone scanning: the assessment of treatment response in carcinoma of the prostate.

Authors:  J M Fitzpatrick; A R Constable; T Sherwood; J J Stephenson; G D Chisholm; E P O'Donoghue
Journal:  Br J Urol       Date:  1978-12

8.  Computerized bone scan. A potentially useful technique to measure response in prostatic carcinoma.

Authors:  A Drelichman; D A Decker; M Al-Sarraf; V K Vaitkevicius; J Muz
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

9.  The value of nuclear bone imaging in advanced prostatic cancer.

Authors:  J J Pollen; K Gerber; W L Ashburn; J D Schmidt
Journal:  J Urol       Date:  1981-02       Impact factor: 7.450

10.  Problems and limitations of bone scanning with the 99Tcm-phosphates.

Authors:  D L Citrin
Journal:  Clin Radiol       Date:  1977-01       Impact factor: 2.350

View more
  5 in total

1.  18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin).

Authors:  Gary Cook; Chris Parker; Sue Chua; Bernadette Johnson; Anne-Kirsti Aksnes; Val J Lewington
Journal:  EJNMMI Res       Date:  2011-06-07       Impact factor: 3.138

2.  The flare phenomenon: far from fair and square.

Authors:  W D van Schelven; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-05

3.  Dynamic quantitative bone scintigraphy in patients with prostatic carcinoma treated by orchiectomy.

Authors:  G M Sundkvist; L Ahlgren; B Lilja; S Mattsson; P A Abrahamsson
Journal:  Eur J Nucl Med       Date:  1990

4.  The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Authors:  Gary J R Cook; Ram Venkitaraman; Aslam S Sohaib; Valerie J Lewington; Sue C Chua; Robert A Huddart; Christopher C Parker; David D Dearnaley; Alan Horwich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-10       Impact factor: 9.236

5.  Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.

Authors:  Christian Uprimny; Anna Svirydenka; Josef Fritz; Alexander Stephan Kroiss; Bernhard Nilica; Clemens Decristoforo; Roland Haubner; Elisabeth von Guggenberg; Sabine Buxbaum; Wolfgang Horninger; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-16       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.